• HOME (current)
  • MEETINGS ARCHIVE
    2019 RANZCO 2018 RANZCO 2017 RANZCO 2016 RANZCO 2015 RANZCO 2014 RANZCO 2013 RANZCO 2012 RANZCO
  • ADVANCED SEARCH
  • 2016 RANZCO HANDBOOK
Home > 2012 RANZCO > FREE PAPERS

Session : FREE PAPERS


SESSION INFORMATION

Date: 25 Nov 2012

Time: 2:00 pm - 3:30 pm

Meeting: 2012 RANZCO

ABSTRACT NUMBER : S04
Rapid Fire Presentations – Glaucoma/Neuro-Ophthalmology
ABSTRACT NUMBER : 0401
GLAUCOMATOUS OPTIC NEUROPATHY EVALUATION (GONE) PROJECT: THE EFFECT OF MONOSCOPIC VERSUS STEREOSCOPIC VIEWING CONDITIONS ON OPTIC NERVE EVALUATION
ABSTRACT NUMBER : 0402
DIRECT MEASUREMENT OF GLAUCOMA SURGICAL OUTFLOW FACILITY USING A NOVEL 3D PRINTED TWO-TUBED GDD
ABSTRACT NUMBER : 0403
SLT MAY COMPROMISE THE CORNEAL ENDOTHELIUM
ABSTRACT NUMBER : 0404
OCULAR SURFACE DISEASE AND QUALITY OF LIFE IN PATIENTS WITH GLAUCOMA
ABSTRACT NUMBER : 0405
TRACER DYE STUDY OF LYMPHATIC CONNECTIONS TO TRABECULECTOMY BLEBS
ABSTRACT NUMBER : 0406
IMMUNE PRIMING AND EXPERIMENTAL GLAUCOMA: THE EFFECT OF PRIOR SYSTEMIC LIPOPOLYSACCHARIDE CHALLENGE ON TISSUE OUTCOMES AFTER OPTIC NERVE INJURY
ABSTRACT NUMBER : 0407
ANTERIOR SEGMENT OCT CHANGES INDUCED BY LASER PERIPHERAL IRIDOPLASTY
ABSTRACT NUMBER : 0408
USING EYE TRACKING TO CHARACTERIZE DEFICITS IN OPTIC DISC EVALUATION IN OPHTHALMOLOGY TRAINEES
ABSTRACT NUMBER : 0409
iSTENT MICRO-TRABECULAR BYPASS SHUNT: EARLY RESULTS FROM A PROSPECTIVE UK SERIES
Advanced Search

MOST VIEWED ABSTRACTS


  • This Week
  • This Month
  • All Time

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Through the Cloudy Lens – Outreach in the Top End

    EFFICACY OF INTRAVITREAL AFLIBERCEPT ADMINISTERED USING TREAT- AND-EXTEND REGIMEN OVER 2 YEARS IN PATIENTS WITH NEOVASCULAR AGE- RELATED MACULAR DEGENERATION: BASELINE CHARACTERISTICS OF ARIES

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    THE CLINICAL USE OF TOPICAL HYPERTONIC SALINE EYE DROPS IN A TERTIARY REFERRAL EYE CARE CENTRE IN SYDNEY, AUSTRALIA

    PERSISTENCE TO AFLIBERCEPT THERAPY IN WET AMD PATIENTS ENGAGED WITH THE SMARTSIGHT SUPPORT PROGRAM

    Nascent Geographic Atrophy (nGA) – an early outcome marker for progression of intermediate Age-related Macular Degeneration (AMD)

    VERTICAL PRISM FUSION RANGES IN A NORMAL POPULATION

RECENT MEETINGS


2019 RANZCO, 51st Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
08 November – 12 November 2019
Sydney, Australia
2018 RANZCO, 50th Annual Scientific Congress of the Royal Australian and New Zealand College of Ophthalmologists
17 November - 21 November 2018
Adelaide Convention Centre, South Australia

ARCHIVES

© COPYRIGHT 2016 The Royal Australian and New Zealand College of Ophthalmologists